Marston, Hugh

The VPAC2 Receptor Is Essential for Circadian Function in the Mouse Suprachiasmatic Nuclei

Harmar, A. J., Marston, H. M., Shen, S., Spratt, C., West, K. M., Sheward, W. J., Morrison, C. F., Dorin, J. R., Piggins, H. D., Reubi, J.-C., et al. (2002) · Cell

Circadian rhythm and melatoninNeuropeptides and Animal Physiology

Cited by 549

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology

Nicotinic Acetylcholine Receptors StudySchizophrenia research and treatment

Cited by 233

Targeting the Synapse in Alzheimer’s Disease

Jackson, J., Jambrina, E., Li, J., Marston, H., Menzies, F., Phillips, K., & Gilmour, G. (2019) · Frontiers in Neuroscience

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 215

Innovative solutions to novel drug development in mental health

Insel, T. R., Voon, V., Nye, J. S., Brown, V. J., Altevogt, B. M., Bullmore, E. T., Goodwin, G. M., Howard, R. J., Kupfer, D. J., Malloch, G., et al. (2013) · Neuroscience & Biobehavioral Reviews

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 124

A quantitative approach to neuropsychiatry: The why and the how

Kas, M. J., Penninx, B., Sommer, B., Serretti, A., Arango, C., & Marston, H. (2019) · Neuroscience & Biobehavioral Reviews

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 112

Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy

Blackmore, T., Meftah, S., Murray, T. K., Craig, P. J., Blockeel, A., Phillips, K., Eastwood, B., O’Neill, M. J., Marston, H., Ahmed, Z., et al. (2017) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 66